Cargando…

Factor structure, measurement invariance, and concurrent validity of the Patient Health Questionnaire-9 and the Generalized Anxiety Disorder scale-7 in a Norwegian psychiatric outpatient sample

OBJECTIVE: The aim of this study was to test factor structure, measurement invariance, and concurrent validity of the nine item Patient Health Questionnaire-9 (PHQ-9) and the seven item Generalized Anxiety Disorder scale-7 (GAD-7) in a heterogeneous outpatient sample. METHOD: Outpatients completed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Brattmyr, Martin, Lindberg, Martin Schevik, Solem, Stian, Hjemdal, Odin, Havnen, Audun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275259/
https://www.ncbi.nlm.nih.gov/pubmed/35818021
http://dx.doi.org/10.1186/s12888-022-04101-z
_version_ 1784745452282839040
author Brattmyr, Martin
Lindberg, Martin Schevik
Solem, Stian
Hjemdal, Odin
Havnen, Audun
author_facet Brattmyr, Martin
Lindberg, Martin Schevik
Solem, Stian
Hjemdal, Odin
Havnen, Audun
author_sort Brattmyr, Martin
collection PubMed
description OBJECTIVE: The aim of this study was to test factor structure, measurement invariance, and concurrent validity of the nine item Patient Health Questionnaire-9 (PHQ-9) and the seven item Generalized Anxiety Disorder scale-7 (GAD-7) in a heterogeneous outpatient sample. METHOD: Outpatients completed the PHQ-9, GAD-7, and the Working Social Adjustment Scale (WSAS) before starting treatment. Study design was cross-sectional, with convenience sampling. The total sample consisted of 831 participants (61% women). RESULTS: Both PHQ-9 and GAD-7 demonstrated better fit statistics with two-factor and bifactor solutions consisting of a cognitive and somatic factor. Omega hierarchical was .78 for PHQ-9 and .81 for GAD-7. Both instruments achieved scalar invariance across gender, diagnosis, and comorbidity. However, the somatic factors demonstrated poor discriminant validity. These factors are not well separatable and risks being too similar if used together. The general factors of both instruments were most associated with functional impairment, although PHQ-9 demonstrated a stronger association with WSAS (γ = .74, r(2) = .62) than GAD-7 (γ = .54, r(2) = .32). Using latent mean difference, women and patients with comorbidity had significantly higher scores of both depression and anxiety. CONCLUSION: This study shows that the PHQ-9 and GAD-7 may be used as one-dimensional instruments in clinical settings. Tests for measurement invariance supported that both measures are understood and interpreted comparably across gender and diagnostic subgroups.
format Online
Article
Text
id pubmed-9275259
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92752592022-07-13 Factor structure, measurement invariance, and concurrent validity of the Patient Health Questionnaire-9 and the Generalized Anxiety Disorder scale-7 in a Norwegian psychiatric outpatient sample Brattmyr, Martin Lindberg, Martin Schevik Solem, Stian Hjemdal, Odin Havnen, Audun BMC Psychiatry Research OBJECTIVE: The aim of this study was to test factor structure, measurement invariance, and concurrent validity of the nine item Patient Health Questionnaire-9 (PHQ-9) and the seven item Generalized Anxiety Disorder scale-7 (GAD-7) in a heterogeneous outpatient sample. METHOD: Outpatients completed the PHQ-9, GAD-7, and the Working Social Adjustment Scale (WSAS) before starting treatment. Study design was cross-sectional, with convenience sampling. The total sample consisted of 831 participants (61% women). RESULTS: Both PHQ-9 and GAD-7 demonstrated better fit statistics with two-factor and bifactor solutions consisting of a cognitive and somatic factor. Omega hierarchical was .78 for PHQ-9 and .81 for GAD-7. Both instruments achieved scalar invariance across gender, diagnosis, and comorbidity. However, the somatic factors demonstrated poor discriminant validity. These factors are not well separatable and risks being too similar if used together. The general factors of both instruments were most associated with functional impairment, although PHQ-9 demonstrated a stronger association with WSAS (γ = .74, r(2) = .62) than GAD-7 (γ = .54, r(2) = .32). Using latent mean difference, women and patients with comorbidity had significantly higher scores of both depression and anxiety. CONCLUSION: This study shows that the PHQ-9 and GAD-7 may be used as one-dimensional instruments in clinical settings. Tests for measurement invariance supported that both measures are understood and interpreted comparably across gender and diagnostic subgroups. BioMed Central 2022-07-11 /pmc/articles/PMC9275259/ /pubmed/35818021 http://dx.doi.org/10.1186/s12888-022-04101-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Brattmyr, Martin
Lindberg, Martin Schevik
Solem, Stian
Hjemdal, Odin
Havnen, Audun
Factor structure, measurement invariance, and concurrent validity of the Patient Health Questionnaire-9 and the Generalized Anxiety Disorder scale-7 in a Norwegian psychiatric outpatient sample
title Factor structure, measurement invariance, and concurrent validity of the Patient Health Questionnaire-9 and the Generalized Anxiety Disorder scale-7 in a Norwegian psychiatric outpatient sample
title_full Factor structure, measurement invariance, and concurrent validity of the Patient Health Questionnaire-9 and the Generalized Anxiety Disorder scale-7 in a Norwegian psychiatric outpatient sample
title_fullStr Factor structure, measurement invariance, and concurrent validity of the Patient Health Questionnaire-9 and the Generalized Anxiety Disorder scale-7 in a Norwegian psychiatric outpatient sample
title_full_unstemmed Factor structure, measurement invariance, and concurrent validity of the Patient Health Questionnaire-9 and the Generalized Anxiety Disorder scale-7 in a Norwegian psychiatric outpatient sample
title_short Factor structure, measurement invariance, and concurrent validity of the Patient Health Questionnaire-9 and the Generalized Anxiety Disorder scale-7 in a Norwegian psychiatric outpatient sample
title_sort factor structure, measurement invariance, and concurrent validity of the patient health questionnaire-9 and the generalized anxiety disorder scale-7 in a norwegian psychiatric outpatient sample
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275259/
https://www.ncbi.nlm.nih.gov/pubmed/35818021
http://dx.doi.org/10.1186/s12888-022-04101-z
work_keys_str_mv AT brattmyrmartin factorstructuremeasurementinvarianceandconcurrentvalidityofthepatienthealthquestionnaire9andthegeneralizedanxietydisorderscale7inanorwegianpsychiatricoutpatientsample
AT lindbergmartinschevik factorstructuremeasurementinvarianceandconcurrentvalidityofthepatienthealthquestionnaire9andthegeneralizedanxietydisorderscale7inanorwegianpsychiatricoutpatientsample
AT solemstian factorstructuremeasurementinvarianceandconcurrentvalidityofthepatienthealthquestionnaire9andthegeneralizedanxietydisorderscale7inanorwegianpsychiatricoutpatientsample
AT hjemdalodin factorstructuremeasurementinvarianceandconcurrentvalidityofthepatienthealthquestionnaire9andthegeneralizedanxietydisorderscale7inanorwegianpsychiatricoutpatientsample
AT havnenaudun factorstructuremeasurementinvarianceandconcurrentvalidityofthepatienthealthquestionnaire9andthegeneralizedanxietydisorderscale7inanorwegianpsychiatricoutpatientsample